The investigator administered [212Pb]VMT-α-NET at 67 µCi/kg (2.5 MBq/kg ... 131 seed assets and related business infrastructure, to GT Medical Technologies, Inc. (GT Medical).

VMT Scientific, Inc. engages in the design, development, testing, and patenting of medical technologies for use in tissue histogenesis. It develops VasCir system, a noninvasive method of assisting ...

Program Highlights VMT-a-NET Company-sponsored Phase 1/2a trial of [212 Pb ... including its radioactive Cesium-131 seed assets and related business infrastructure, to GT Medical Technologies, Inc.